Page last updated: 2024-10-20

pteridines and Leishmaniasis, Mucocutaneous

pteridines has been researched along with Leishmaniasis, Mucocutaneous in 1 studies

Leishmaniasis, Mucocutaneous: A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sampaio, MC1
Barbosa, AF1
Este, MG1
Pirmez, C1
Bello, AR1
Traub-Csekö, YM1

Other Studies

1 other study available for pteridines and Leishmaniasis, Mucocutaneous

ArticleYear
A 245kb mini-chromosome impacts on Leishmania braziliensis infection and survival.
    Biochemical and biophysical research communications, 2009, Apr-24, Volume: 382, Issue:1

    Topics: Animals; Cell Line; Chromosomes; Gene Amplification; Insect Vectors; Leishmania braziliensis; Leishm

2009